Q2 2024

Filed Jul 29, 2024 · 10-Q · 29 days after period end · 0000950170-24-087322

Q2 2024 · 10-Q

Revenue

$17.49B

+10.3% vs Q2 2023

Net Income

$1.46B

+22.5% vs Q2 2023

EPS Diluted

$5.53

+28.9% vs Q2 2023

Operating Cash Flowderived$1,971,000,000−20.4%

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$17.49B	$15.86B	$14.82B	$14.44B
Net Income	$1.46B	$1.19B	$1.16B	$1.45B
EPS Diluted	$5.53	$4.29	$3.90	$4.36

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

HCA Healthcare, Inc. · CIK 860730 · Engraved from SEC EDGAR